Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NDMA

This article was originally published in The Tan Sheet

Executive Summary

Submits petition on iron-containing dietary supplements to FDA and CPSC on Oct. 15, asking the agencies to officially adopt the proposal as a regulation. NDMA also requested that "other petitions which may have been submitted on the subject . . . be denied insofar as they would contradict, add to, or subtract from the NDMA program." The proposal is essentially identical to NDMA's voluntary program and education campaign that was unveiled at a Sept. 28 CPSC conference to address accidental iron poisonings in young children ("The Tan Sheet" Oct. 4, p. 14). Thirty-four state attorneys general also have petitioned the agency to adopt their proposal as the basis for a regulation ("The Tan Sheet" Aug. 30, p. 14).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel